Novo Nordisk receives FDA warning regarding US inspection in 2025

Novo Nordisk receives FDA warning regarding US inspection in 2025 | ReutersSkip to main contentExclusive news, data and analytics for financial market professionalsLearn more aboutRefinitivThe logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, November 24, 2025. REUTERS/Tom Little Purchase Licensing Rights, opens new tab- CompaniesNovo Nordisk A/SFollowU.S. Food and Drug AdministrationFollowCOPENHAGEN, March 10 (Reuters) - ...